Westwood, Samuel J. http://orcid.org/0000-0002-0107-6651
Parlatini, Valeria http://orcid.org/0000-0002-4754-2494
Rubia, Katya http://orcid.org/0000-0002-1410-7701
Cortese, Samuele
Sonuga-Barke, Edmund J. S.
Banaschewski, T.
Baeyens, D.
Bölte, S.
Brandeis, D.
Buitelaar, J.
Carucci, S.
Coghill, D.
Daley, D.
Döpfner, M.
Ferrin, M.
Galera, C.
Hollis, C.
Holtmann, M.
Purper-Ouakil, D.
Nagy, P.
Santosh, P.
Simonoff, E.
Sonuga-Barke, E. J.
Soutullo, C. A.
Stringaris, A.
Thapar, A.
van der Oord, S.
van den Hoofdakker, B. J.
Zuddas, A.
,
Article History
Received: 1 August 2022
Revised: 1 February 2023
Accepted: 10 February 2023
First Online: 29 March 2023
Competing interests
: SJW and VP declare not conflicts of interest. KR has received a grant from Takeda pharmaceuticals and consulting fees from Supernus and Lundbeck. She is supported by the UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and the Maudsley National Health Service (NHS) Foundation Trust and the IoPPN, King’s College London. SCo declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP), and from Healthcare Convention for educational activity on ADHD. ESB reports being an speaker for Medice and Shire (Takeda) in the last three years; being a consultant for Neurotech Solutions International; holding grant funding from QBTech; receiving an annual honorarium from the JCPP.CH declares funding from the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre and MindTech Medtech Co-operative. PS is the CEO and shareholder of HealthTracker Ltd and has received research funds from Newron Pharmaceuticals SpA, GWPharma, and Anavex Life Sciences Corp.